Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)

NCT02989857 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

187

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cholangiocarcinoma
Metastatic Cholangiocarcinoma

Interventions

DRUG: AG-120
DRUG: Placebo

Sponsor

Institut de Recherches Internationales Servier